Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Deluxe
DLX
$1.05B
| $272K | ﹤0.01% |
9,886
-67,533
| -87% | -$1.77M |
2013 Q2
51 quarters
|
|
3477
Hanover Bancorp
HNVR
$178M
| $272K | ﹤0.01% |
12,594
+1,925
| +18% | +$42.8K |
2024 Q3
6 quarters
|
|
3478
2x Long VIX Futures ETF
UVIX
$197M
| $272K | ﹤0.01% |
1,569
-105
| -6% | -$14.1K |
2025 Q2
3 quarters
|
|
3479
Century Therapeutics
IPSC
$292M
| $272K | ﹤0.01% |
120,232
+120,231
| +12,023,100% | +$253K |
2022 Q1
16 quarters
|
|
|
NAVN
3480
Navan Inc
NAVN
$5.6B
| $271K | ﹤0.01% |
20,505
-37,876
| -65% | -$450K |
2025 Q4
1 quarter
|
|
3481
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.6B
| $271K | ﹤0.01% |
1,862
+717
| +63% | +$108K |
2019 Q2
27 quarters
|
|
3482
Information Services Group
III
$278M
| $271K | ﹤0.01% |
70,566
-53,169
| -43% | -$262K |
2019 Q1
28 quarters
|
|
|
SEZL
3483
Sezzle
SEZL
$3.69B
| $271K | ﹤0.01% |
4,279
-21,074
| -83% | -$1.44M |
2024 Q1
8 quarters
|
|
3484
TAT Technologies
TATT
$453M
| $270K | ﹤0.01% |
6,647
+6,472
| +3,698% | +$335K |
2025 Q1
4 quarters
|
|
|
OGG
3485
Osisko Gold Group
OGG
$853M
| $268K | ﹤0.01% |
82,596
-237,888
| -74% | -$885K |
2024 Q2
7 quarters
|
|
3486
Tenax Therapeutics
TENX
$72.2M
| $267K | ﹤0.01% |
+16,698
| New | +$226K |
2026 Q1
0 quarters
|
|
3487
NWPX Infrastructure Inc
NWPX
$1.01B
| $267K | ﹤0.01% |
3,428
-12,716
| -79% | -$918K |
2016 Q4
37 quarters
|
|
3488
Hagerty
HGTY
$1.5B
| $267K | ﹤0.01% |
25,333
| – | – |
2023 Q1
12 quarters
|
|
3489
Inogen
INGN
$159M
| $266K | ﹤0.01% |
43,087
-38,893
| -47% | -$240K |
2014 Q1
48 quarters
|
|
3490
ProShares Short VIX Short-Term Futures ETF
SVXY
$258M
| $266K | ﹤0.01% |
5,810
| – | – |
2021 Q1
20 quarters
|
|
|
OSG
3491
Octave Specialty Group
OSG
$194M
| $265K | ﹤0.01% |
56,969
-623,472
| -92% | -$3.57M |
2013 Q2
51 quarters
|
|
3492
Sylvamo
SLVM
$1.32B
| $265K | ﹤0.01% |
6,268
-47,365
| -88% | -$2.22M |
2022 Q1
16 quarters
|
|
3493
Franklin Covey
FC
$197M
| $264K | ﹤0.01% |
16,729
-13,445
| -45% | -$221K |
2017 Q1
36 quarters
|
|
3494
Employers Holdings
EIG
$874M
| $264K | ﹤0.01% |
6,405
-28,445
| -82% | -$1.2M |
2016 Q1
40 quarters
|
|
3495
LifeVantage
LFVN
$78.6M
| $263K | ﹤0.01% |
60,914
+12,663
| +26% | +$66.3K |
2018 Q3
30 quarters
|
|
3496
Cabaletta Bio
CABA
$320M
| $263K | ﹤0.01% |
97,792
-122,904
| -56% | -$341K |
2022 Q1
16 quarters
|
|
3497
First Western Financial
MYFW
$290M
| $263K | ﹤0.01% |
10,692
-11,096
| -51% | -$281K |
2020 Q2
23 quarters
|
|
3498
ProKidney
PROK
$357M
| $262K | ﹤0.01% |
146,284
-23,717
| -14% | -$50.3K |
2023 Q2
11 quarters
|
|
3499
Quantum Computing Inc
QUBT
$1.9B
| $261K | ﹤0.01% |
38,105
-1,062,869
| -97% | -$9.72M |
2025 Q1
4 quarters
|
|
3500
Qfin Holdings
QFIN
$785M
| $261K | ﹤0.01% |
20,208
-425,274
| -95% | -$6.54M |
2020 Q2
23 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.